In a study on effect of telbivudine therapy on the cellular immune response in chronic hepatitis B, it was found that the decrease in serum HBV DNA levels was associated with an increase in IFN-γ and TNF-α production by HBV antigen-specific T cells. Here, IFNG is linked to chronic hepatitis B virus infection.